Health Canada approves new therapy Jascayd (nerandomilast) for adults with IPF and PPF, offering an option to slow lung ...

Mobility issues have prompted columnist Sam Kirton to downsize, but he will miss the lakefront house that he and his wife called home.

Cold and flu season can be stressful with PF, so columnist Kylene Henderson plans ahead so her family can still enjoy the ...

Oral therapy admilparant slowed lung function decline in people with idiopathic pulmonary fibrosis (IPF) in a Phase 3 ...

Columnist Ann Reynoso pays tribute to a special respiratory therapist who guided her during her pulmonary rehabilitation ...

Columnist Sam Kirton recalls some of the scariest moments since his IPF diagnosis, and invites readers to share their own experiences.

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google As my regular readers may remember, I am prescribed supplemental ...

The U.S. Food and Drug Administration (FDA) will decide by early next year whether or not to expand its approval of nebulized Tyvaso (treprostinil) — an inhaled treatment for people with certain lung ...

A new type of pericyte called Peri2 is linked to scar tissue formation in the lungs of people with pulmonary fibrosis (PF), according to a study. Pericytes are cells that surround blood vessels. A ...

The inhaled therapy MNKD-201 was tolerated well in people with idiopathic pulmonary fibrosis (IPF) in a Phase 1 clinical trial, and a Phase 2 study to further test it is underway, the treatment’s ...